CollPlant Biotechnologies Ltd. (CLGN)
1.67
-0.14
(-7.73%)
USD |
NASDAQ |
Dec 15, 16:00
1.65
-0.02
(-1.20%)
After-Hours: 20:00
CollPlant Biotechnologies EPS Diluted (Quarterly): -0.2738 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Compugen Ltd. | -0.0746 |
| Can-Fite BioPharma Ltd. | -- |
| BiomX, Inc. | -5.546 |
| Nasus Pharma Ltd. | -- |
| Regentis Biomaterials Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.483M |
| Revenue (Quarterly) | 0.077M |
| Total Expenses (Quarterly) | 3.56M |
| Enterprise Value | 15.45M |
| Gross Profit Margin (Quarterly) | -539.0% |
| Profit Margin (Quarterly) | -4.52K% |
| Earnings Yield | -61.19% |
| Normalized Earnings Yield | -61.19 |